Monday, April 22, 2024

USPSTF Urges Abuse Screening for Reproductive-Aged Women

Evidence lacking for assessing balance of benefits, harms of screening for abuse of seniors, vulnerable

TUESDAY, April 24, 2018 (HealthDay News) — The U.S. Preventive Services Task Force (USPSTF) has found that screening for intimate partner violence (IPV) is beneficial for reproductive-aged women, while there is inadequate evidence to weigh the balance of benefits and harms of screening for abuse in elderly and vulnerable adults. These findings form the basis of a draft recommendation statement published online April 24 by the USPSTF.

Researchers from the USPSTF reviewed the evidence on screening for IPV and abuse of elderly and vulnerable adults. Data were reviewed from 30 studies with 14,959 participants.

The researchers found that there was adequate evidence that available screening instruments can identify IPV in women. The evidence was adequate that effective interventions can reduce violence, abuse, and physical or mental harms for reproductive-aged women. Consequently, the USPSTF recommends that clinicians screen for IPV in women of reproductive age (B recommendation). Inadequate evidence was found for assessing the accuracy of screening instruments designed to detect abuse of elders or vulnerable adults; therefore, the USPSTF concludes that the current evidence is insufficient to weigh the balance and harms of screening (I recommendation). These findings form the basis of a draft recommendation statement, which is available for public comment from April 24 to May 21.

“Clinicians can make a real difference for women suffering from intimate partner violence by helping identify them and getting them the support they need,” Task Force member John Epling, M.D., said in a statement. “The Task Force found that screening tools can help detect intimate partner violence among women and ongoing support services can reduce physical and sexual violence and psychological abuse.”

Draft Recommendation Statement

Draft Evidence Review

Comment on Recommendation

Copyright © 2018 HealthDay. All rights reserved.